Literature DB >> 25567596

[Hepatic epithelioid angiomyolipoma: a clinicopathologic analysis of 25 cases].

Huan Xu1, Huan Wang1, Xiuhui Zhang1, Gandi Li2.   

Abstract

OBJECTIVE: To study the clinicopathologic features, immunophenotype, histological diagnosis and prognosis of hepatic epithelioid angiomyolipoma.
METHODS: Clinical data of 25 cases of hepatic epithelioid angiomyolipoma were collected along with follow-up study of the patients. The pathological features were documented and immunohistochemical study of various markers was performed with an emphasis on diagnosis and differential diagnosis.
RESULTS: Hepatic epithelioid angiomyolipoma was more commonly found in young women without characteristic clinical symptoms. Its morphological features were characterized by marked cytological atypia, relatively rare mitotic figures; radial distribution of tumor cells around the thin-walled blood vessels or muscular vessels; and the presence of common multinucleated giant cells and large ganglion-like tumor cells. The tumor cells expressed both melanoma cell markers (HMB45, MART-1) and smooth muscle cell markers (SMA). Tumor cells expressed various other markers including ER 16% (4/25), PR 32% (8/25), TFE3 24% (6/25) and p53 60% (15/25).
CONCLUSIONS: Hepatic epithelioid angiomyolipoma has variable morphological features and characteristic immunohistochemical phenotype. The differential diagnoses include a variety of tumors. The biological behavior of the tumor tends to be benign.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25567596

Source DB:  PubMed          Journal:  Zhonghua Bing Li Xue Za Zhi        ISSN: 0529-5807


  1 in total

Review 1.  Primary hepatic epithelioid angiomyolipoma: A malignant potential tumor which should be recognized.

Authors:  Jie Liu; Cheng-Wu Zhang; De-Fei Hong; Ran Tao; Yuan Chen; Min-Jie Shang; Yu-Hua Zhang
Journal:  World J Gastroenterol       Date:  2016-05-28       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.